Skip to main content
    C

    Corbus Pharmaceuticals Holding (CRBP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.38
    -0.02 (-0.44%)

    Market Cap: $69.86M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Corbus Pharmaceuticals Holding (CRBP) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Corbus Pharmaceuticals Holding (CRBP) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, Corbus Pharmaceuticals Holding reported EPS of -$1.81, below the -$1.45 estimate. It beat the EPS estimate in 2 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    40%(16/40)
    Avg Surprise
    -5.10%

    Upcoming Estimates

    Reports Mar 8, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$1.42
    Range-$1.96 - -$0.78
    12 analysts
    Revenue Consensus
    N/A
    RangeN/A
    10 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$1.21
    Range-$1.51 - -$0.96
    3 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$1.24+2.9%
    60d ago-$1.24+2.9%
    30d ago-$1.24+2.9%
    7d ago-$1.24+2.9%
    Current-$1.21
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts

    Next Report

    CRBP has an expected report date of Mar 8, 2027.

    Earnings History

    Of the 40 quarters below that had an estimate, CRBP beat 16, missed 23 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $1.08M, down 4.4% from $1.13M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$1.81-$1.45-$1.91 - -$0.73-24.83%MissN/A100 up, 1 downNov 10, 2026$1.08M
    Jun 30, 2026-$1.81-$1.30-$1.38 - -$1.15-39.23%MissN/A100 up, 3 downAug 6, 2026$1.16M
    Mar 31, 2026-$1.23-$1.22-$1.37 - -$1.02-0.82%MissN/A83 up, 2 downMay 12, 2026$1.40M
    Dec 31, 2025-$1.25-$1.58-$3.57 - -$0.94+20.69%BeatN/A104 up, 5 downMar 9, 2026$1.41M
    Sep 30, 2025-$1.90-$1.71-$3.27 - -$1.43-11.11%MissN/A102 up, 6 downNov 12, 2025$1.13M
    Jun 30, 2025-$1.44-$1.33-$1.65 - -$0.86-8.27%MissN/A92 up, 4 downAug 5, 2025$1.31M
    Mar 31, 2025-$1.39-$1.07-$1.30 - -$0.87-29.91%MissN/A73 up, 0 downMay 6, 2025$1.68M
    Dec 31, 2024-$0.78-$1.26-$1.52 - -$1.02+38.04%BeatN/A90 up, 1 downMar 11, 2025$4.71M
    Sep 30, 2024-$1.15-$0.95-$1.14 - -$0.74-21.05%MissN/A80 up, 0 downNov 7, 2024N/A
    Jun 30, 2024-$0.90-$1.19-$1.71 - -$0.80+24.37%BeatN/A60 up, 0 downAug 6, 2024$1.60M
    Mar 31, 2024-$0.83-$1.09-$1.22 - -$0.96+23.85%BeatN/A20 up, 0 downMay 7, 2024N/A
    Dec 31, 2023-$1.81-$2.36-$2.50 - -$2.22+23.31%BeatN/A20 up, 0 downMar 12, 2024$1.64M
    Sep 30, 2023-$2.27-$2.06-$2.06 - -$2.06-10.19%MissN/A10 up, 0 downNov 7, 2023N/A
    Jun 30, 2023-$2.05-$3.10-$3.10 - -$3.10+33.87%BeatN/A10 up, 0 downAug 8, 2023N/A
    Mar 31, 2023-$4.24-$4.09-$4.09 - -$4.09-3.67%MissN/A10 up, 0 downMay 9, 2023N/A
    Dec 31, 2022-$2.61-$2.10-$2.40 - -$1.80-24.29%MissN/A30 up, 0 downMar 7, 2023N/A
    Sep 30, 2022-$2.10-$1.65-$2.10 - -$1.20-27.27%MissN/A20 up, 0 downNov 8, 2022N/A
    Jun 30, 2022-$3.30-$1.80-$2.10 - -$1.50-83.33%MissN/A20 up, 0 downAug 9, 2022N/A
    Mar 31, 2022-$2.40-$2.55-$3.30 - -$1.80+5.88%BeatN/A20 up, 0 downMay 10, 2022N/A
    Dec 31, 2021-$2.40-$3.22-$3.60 - -$3.00+25.47%BeatN/A4N/AMar 8, 2022N/A
    Sep 30, 2021-$0.60-$3.30-$3.90 - -$2.70+81.82%BeatN/A4N/ANov 12, 2021$97323
    Jun 30, 2021-$4.50-$3.75-$3.90 - -$2.70-20.00%MissN/A5N/AAug 12, 2021$136558
    Mar 31, 2021-$4.20-$4.80-$5.71 - -$3.30+12.50%BeatN/A5N/AMay 13, 2021$647824
    Dec 31, 2020-$3.00-$7.56-$11.71 - -$4.50+60.32%BeatN/A5N/AMar 15, 2021$658204
    Sep 30, 2020-$12.90-$12.18-$15.62 - -$9.91-5.91%MissN/A7N/ANov 10, 2020$1.23M
    Jun 30, 2020-$15.60-$11.25-$13.81 - -$9.61-38.67%Miss-1833.3%7N/AAug 6, 2020$286346
    Mar 31, 2020-$12.90-$12.70-$15.32 - -$9.31-1.57%MissN/A6N/AMay 11, 2020$1.76M
    Dec 31, 2019-$12.30-$10.74-$12.01 - -$6.91-14.53%MissN/A5N/AMar 12, 2020$2.57M
    Sep 30, 2019-$9.60-$10.90-$12.91 - -$9.61+11.93%BeatN/A5N/ANov 7, 2019$2.59M
    Jun 30, 2019$0.90-$10.68-$13.21 - -$9.31+108.43%BeatN/A5N/AAug 8, 2019$29.09M
    Mar 31, 2019-$12.90-$4.45N/A-189.89%MissN/A5N/AMay 9, 2019$1.89M
    Dec 31, 2018-$9.00-$7.80-$8.71 - -$6.61-15.38%MissN/A6N/AMar 12, 2019$1.93M
    Sep 30, 2018-$7.80-$6.65-$7.51 - -$6.01-17.29%MissN/A6N/ANov 8, 2018$1.09M
    Jun 30, 2018-$6.30-$6.45-$6.91 - -$6.01+2.33%BeatN/A4N/AAug 8, 2018$853646
    Mar 31, 2018-$6.30-$4.10-$6.31 - -$2.40-53.66%MissN/A3N/AMay 10, 2018$950442
    Dec 31, 2017-$6.30-$4.62-$5.11 - -$4.20-36.36%MissN/A5N/AMar 12, 2018N/A
    Sep 30, 2017-$4.20-$4.80-$5.11 - -$4.50+12.50%BeatN/A3N/ANov 8, 2017$796312
    Jun 30, 2017-$4.50-$5.60-$6.01 - -$5.11+19.64%BeatN/A3N/AAug 9, 2017$350186
    Mar 31, 2017-$4.80-$4.80N/A0.00%In lineN/AN/AN/AMay 9, 2017$1.29M
    Dec 31, 2016-$5.40-$4.10N/A-31.71%MissN/AN/AN/AMar 9, 2017$375670
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$5.98, after -$3.66 the year before. It was -$14.70 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$5.98N/A
    Dec 31, 2024-$3.66N/A
    Dec 31, 2023-$10.37N/A
    Dec 31, 2022-$10.41N/A
    Dec 31, 2021-$11.70N/A
    Dec 31, 2020-$44.40N/A
    Dec 31, 2019-$33.90N/A
    Dec 31, 2018-$29.40N/A
    Dec 31, 2017-$19.80N/A
    Dec 31, 2016-$14.70N/A

    Frequently Asked Questions About CRBP

    When is Corbus Pharmaceuticals Holding's next earnings date?

    Corbus Pharmaceuticals Holding's next earnings report is expected for Mar 8, 2027.

    Did CRBP beat earnings estimates last quarter?

    No. Corbus Pharmaceuticals Holding reported EPS of -$1.81 for the quarter ended Sep 30, 2026, below the -$1.45 estimate by 24.83%.

    What EPS do analysts expect from CRBP next quarter?

    The consensus EPS estimate for Corbus Pharmaceuticals Holding for the quarter ending Dec 31, 2026 is -$1.42 from 12 analysts, with estimates from -$1.96 to -$0.78.

    How often does CRBP beat earnings estimates?

    Corbus Pharmaceuticals Holding beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -6.93%.